Article Details
Retrieved on: 2019-03-16 21:39:50
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div><b>Vanguard Group</b> Inc. lifted its position in Melinta Therapeutics Inc (NASDAQ:MLNT) by 4.5% in the third quarter, according to its most recent Form 13F ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here